- Home
- Liposomal Extracts
- Liposomal Indian Frankincense Extract
Liposomal Indian Frankincense Extract (Boswellia serrata) – Boswellic Acids 20%
Boswellia serrata
- Marker compound
- Boswellic acids
- Standardisation
- 20% (HPLC, Titration)
- Assay method
- HPLC, Titration
- Plant part
- Resin & Gum
- Origin
- India
Liposomal Indian Frankincense Extract (Boswellia serrata) – Boswellic Acids 20%
Indian Frankincense extract is produced from the gum resin of Boswellia serrata (Burseraceae family) and supplied as a liposomal (phospholipid-encapsulated) powder, standardized to Boswellic acids. Available grades: 20%. Typical sourcing: India. For B2B formulation in nutraceuticals & supplements.
20%
Specifications
| Botanical name | Boswellia serrata |
| Common names | Indian frankincense |
| Plant family / part | Burseraceae / Gum resin |
| Marker compound | Boswellic acids |
| Phytochemical class | Terpenoids › Triterpenoids & triterpene saponins |
| Available grades | 20% |
| Assay method | HPLC, Titration |
| Pharmacopoeia & standards | USP, Ph. Eur. (EP), Indian Pharmacopoeia, Ayurvedic Pharmacopoeia of India |
| Form | Liposomal Extract |
| Origin | India |
| Pack sizes | Sample (50 g), 250 g, 1 Kg, 5 Kg, 25 Kg |
| Shelf life & storage | Typically 24 months in sealed original packaging; store cool, dry and away from light |
Formulation focus
- Joint & Bone Health
- Respiratory Health
- Healthy Inflammation Response
Industries
Nutraceuticals & Supplements
Traditional systems: Ayurveda
Documentation
The Technical Data Sheet and Safety Data Sheet (GHS format) can be downloaded from this page; the batch Certificate of Analysis is supplied on request. Confirm the assay method (HPLC, UV or gravimetric) on the CoA, as results differ between methods.
For B2B formulation and research use. Statements have not been evaluated by the FDA or other regulators; this ingredient is not intended to diagnose, treat, cure or prevent any disease.
Same product form